4/A//SEC Filing
Spring Bank Pharmaceuticals, Inc. 4/A
Accession 0001209191-16-137309
CIK 0001566373operating
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 6:13 PM ET
Size
6.1 KB
Accession
0001209191-16-137309
Insider Transaction Report
Form 4/AAmended
Afdhal Nezam H.
Chief Medical Officer
Transactions
- Purchase
Common Stock
2016-08-10$10.81/sh+1,600$17,300→ 32,850 total - Purchase
Common Stock
2016-08-12$11.32/sh+1,000$11,318→ 33,850 total
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001566373
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 6:13 PM ET
- Size
- 6.1 KB